MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
0.9800
-0.0800 (-7.55%)
At close: Mar 31, 2025, 4:00 PM
0.9923
+0.0123 (1.26%)
After-hours: Mar 31, 2025, 7:56 PM EDT

MIRA Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-7.85-11.98-7.06-2.18-0.2
Other Amortization
-0.73---
Stock-Based Compensation
1.922.551.3--
Other Operating Activities
-3.710.010.02-
Change in Accounts Receivable
--0.01---
Change in Accounts Payable
0.18-0.390.150.78-
Change in Other Net Operating Assets
0.190.86-0.01--
Operating Cash Flow
-5.56-4.53-5.6-1.38-0.2
Short-Term Debt Issued
-2.15-0.2-
Total Debt Issued
-2.15-0.20.27
Short-Term Debt Repaid
--1.14-0.16--
Total Debt Repaid
--1.14-0.16--
Net Debt Issued (Repaid)
-1.01-0.160.20.27
Issuance of Common Stock
3.617.72.94.51-
Other Financing Activities
0.180.070.4-0.53-0.06
Financing Cash Flow
3.798.783.154.180.21
Net Cash Flow
-1.774.25-2.462.810.01
Levered Free Cash Flow
-4.64-4.73-3-0.66-
Unlevered Free Cash Flow
-4.64-3.3-2.99-0.64-
Change in Net Working Capital
-0.370.52-0.12-0.7-
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q